Tags |
|
|
Links |
|
|
Useful Articles - Shakeouts
This phenomenon occurs in the realms of day trading as well as longer-term investing. In both areas, the
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
masters of the market try to “shake” other traders out of promising long or short positions by precipitat
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ng quick reversals in the prevailing trend.
For example, news plays are the foundation of day trading wh
For example, news plays are the foundation of day trading wh
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
ere speed is essential. A positive headline for stock ABC is usually followed by a spike in buy volume th
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
t shoots the price higher. This can last five minutes or less. The spike is often followed by a shake in
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
which the price falls sharply as the surge in volume subsides and early birds sell and pocket their profi
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
s. A typical retracement is 50%. So if ABC jumps from 10 to 11, it tends to drop to around 10.50.
This i
This i
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
s usually enough to scare out traders who came late to the party and bought ABC around 11. The shake is u
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
ually followed by another substantial move higher, and that’s where savvy traders jump back into the stoc
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
k for further profits.
In longer-term positions, a shake often triggers the stop losses that wise invest
In longer-term positions, a shake often triggers the stop losses that wise invest
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
rs place below their entry price (or above in the case of a short). They “trail” the stop behind the stoc
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
as the price advances. We usually recommend using a 10% stop loss; if you buy ABC at 10, you place the s
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
top loss at 9. If ACB rises to 11, you adjust the stop to 10 or so. If it hits 12 you adjust to around 11
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
and so on. Using a stop protects your position against severe loss and locks in profits.
But market mak
But market mak
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
ers have an uncanny ability to judge where the majority of stops are sitting for a particular stock. If A
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
C is at 12 and loads of stops are at 11, it’s usual to see enough selling hit the stock to take in down t
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
o 11 and trigger all those stops. That shakes investors out of their position as the stock is sold.
It i
It i
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
frustrating to be shaken out of a good position only to watch the stock resume its winning move, but it
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
is the way the game is played. It’s no reason to quit using stops, because all too often a reversal can w
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
ack 20 or 30% off the price of a stock before it regains its footing. We don’t want to be around for that
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.usefularticles.org.ua/article/104010/usefularticles-Shakeouts.html">Shakeouts</a>
BB link (for phorums):
[url=http://www.usefularticles.org.ua/article/104010/usefularticles-Shakeouts.html]Shakeouts[/url]
Related Articles:
Starting up Your Own Ice Cream Parlor
How to Be a Persuasive Salesperson
Profiting from Terrible Keyword Supply and Demand Ratios
Bookmark it:
|